<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7277397\results\search\disease\results.xml">
  <result pre="addition to direct medical issues. The rapid spread of severe" exact="acute" post="respiratory syndrome-coronavirus (SARS-CoV)-2 to almost every country on the"/>
  <result pre="to direct medical issues. The rapid spread of severe acute" exact="respiratory" post="syndrome-coronavirus (SARS-CoV)-2 to almost every country on the globe"/>
  <result pre="country on the globe and the failure to contain the" exact="infections" post="have contributed to fear and panic worldwide. The lack"/>
  <result pre="COVID-19 too. Moreover, existing antivirals used for other types of" exact="viral" post="infections have been considered as urgent action is necessary."/>
  <result pre="too. Moreover, existing antivirals used for other types of viral" exact="infections" post="have been considered as urgent action is necessary. This"/>
  <result pre="and potential innovative novel approaches in progress. coronavirus peptide vaccine" exact="viral" post="vectors gene silencing RNA interference viral replication 1. Introduction"/>
  <result pre="progress. coronavirus peptide vaccine viral vectors gene silencing RNA interference" exact="viral" post="replication 1. Introduction Coronaviruses belong to the family Coronaviridae"/>
  <result pre="belong to the family Coronaviridae and are characterized by causing" exact="respiratory" post="tract infections ranging from mild diseases such as common"/>
  <result pre="the family Coronaviridae and are characterized by causing respiratory tract" exact="infections" post="ranging from mild diseases such as common cold to"/>
  <result pre="infections ranging from mild diseases such as common cold to" exact="pneumonia" post="with a lethal outcome [1]. Typically, coronaviruses have been"/>
  <result pre="cats and dogs (Table 1) [2]. In this context, transmissible" exact="gastroenteritis" post="virus (TGEV) [3] and porcine epidemic diarrhea virus (PEDV)"/>
  <result pre="this context, transmissible gastroenteritis virus (TGEV) [3] and porcine epidemic" exact="diarrhea" post="virus (PEDV) [4] are responsible for significant morbidity and"/>
  <result pre="significant morbidity and mortality in young piglets. Similarly, porcine hemagglutinating" exact="encephalomyelitis" post="virus (PHEV) causes enteric infection in pigs but can"/>
  <result pre="young piglets. Similarly, porcine hemagglutinating encephalomyelitis virus (PHEV) causes enteric" exact="infection" post="in pigs but can also lead to encephalitis by"/>
  <result pre="causes enteric infection in pigs but can also lead to" exact="encephalitis" post="by targeting the nervous system [5]. In cattle, bovine"/>
  <result pre="cattle, bovine CoV (BCoV) is responsible for mild to severe" exact="respiratory" post="tract infections, resulting in significant losses in the cattle"/>
  <result pre="cattle industry due to diarrhea, dehydration, decreased milk production and" exact="depression" post="[6,7]. In addition to cattle, BCoV also infects other"/>
  <result pre="elk, deer and camels. Another coronavirus, rat CoV (RCoV), causes" exact="respiratory" post="tract infections in rats, providing a useful model for"/>
  <result pre="and camels. Another coronavirus, rat CoV (RCoV), causes respiratory tract" exact="infections" post="in rats, providing a useful model for studying early"/>
  <result pre="for studying early events of innate immune responses to coronavirus" exact="infections" post="in lungs [8]. Infectious bronchitis virus (IBV) targets chickens,"/>
  <result pre="of innate immune responses to coronavirus infections in lungs [8]." exact="Infectious" post="bronchitis virus (IBV) targets chickens, causing respiratory tract infections"/>
  <result pre="innate immune responses to coronavirus infections in lungs [8]. Infectious" exact="bronchitis" post="virus (IBV) targets chickens, causing respiratory tract infections but"/>
  <result pre="in lungs [8]. Infectious bronchitis virus (IBV) targets chickens, causing" exact="respiratory" post="tract infections but also renal disease [9]. IBV has"/>
  <result pre="[8]. Infectious bronchitis virus (IBV) targets chickens, causing respiratory tract" exact="infections" post="but also renal disease [9]. IBV has a significant"/>
  <result pre="virus (IBV) targets chickens, causing respiratory tract infections but also" exact="renal disease" post="[9]. IBV has a significant negative effect on egg"/>
  <result pre="(IBV) targets chickens, causing respiratory tract infections but also renal" exact="disease" post="[9]. IBV has a significant negative effect on egg"/>
  <result pre="chicken industry [7]. In domestic cats, a mild or asymptomatic" exact="infection" post="has been associated with feline enteric coronavirus (FCoV) [10],"/>
  <result pre="coronavirus (FCoV) [10], although a highly virulent strain of feline" exact="infectious" post="peritonitis virus (FIPV) causes lethal feline infectious peritonitis (FIP)"/>
  <result pre="(FCoV) [10], although a highly virulent strain of feline infectious" exact="peritonitis" post="virus (FIPV) causes lethal feline infectious peritonitis (FIP) [11],"/>
  <result pre="strain of feline infectious peritonitis virus (FIPV) causes lethal feline" exact="infectious" post="peritonitis (FIP) [11], which shows similarities to human sarcoidosis"/>
  <result pre="of feline infectious peritonitis virus (FIPV) causes lethal feline infectious" exact="peritonitis" post="(FIP) [11], which shows similarities to human sarcoidosis [12]."/>
  <result pre="feline infectious peritonitis (FIP) [11], which shows similarities to human" exact="sarcoidosis" post="[12]. Interestingly, wildlife can also be infected by coronaviruses."/>
  <result pre="deceased Beluga whale [13]. The whale had suffered from a" exact="respiratory" post="disease and acute liver failure and large quantities of"/>
  <result pre="Beluga whale [13]. The whale had suffered from a respiratory" exact="disease" post="and acute liver failure and large quantities of SW1"/>
  <result pre="[13]. The whale had suffered from a respiratory disease and" exact="acute" post="liver failure and large quantities of SW1 particles were"/>
  <result pre="The whale had suffered from a respiratory disease and acute" exact="liver failure" post="and large quantities of SW1 particles were isolated from"/>
  <result pre="identify the virus as a coronavirus, but nucleic acid sequencing" exact="of liver" post="tissue confirmed the presence of coronavirus RNA. Phylogenetic analysis"/>
  <result pre="have been identified [14]. In this context, both the severe" exact="acute" post="respiratory syndrome-coronavirus (SARS-CoV) and the Middle East respiratory syndrome-CoV"/>
  <result pre="been identified [14]. In this context, both the severe acute" exact="respiratory" post="syndrome-coronavirus (SARS-CoV) and the Middle East respiratory syndrome-CoV (MERS-CoV)"/>
  <result pre="the severe acute respiratory syndrome-coronavirus (SARS-CoV) and the Middle East" exact="respiratory" post="syndrome-CoV (MERS-CoV) have been suggested to originate from bats."/>
  <result pre="pose a threat for human epidemics [15]. For instance, the" exact="disease" post="potential of a SARS-like virus, SHC014-CoV, circulating in Chinese"/>
  <result pre="human angiotensin-converting enzyme 2 (ACE2), replicate to high levels in" exact="primary" post="human airway cells and generate in vitro titers equivalent"/>
  <result pre="a reality today, as will be discussed below. The murine" exact="hepatitis" post="virus (MHV) is the best studied animal coronavirus resulting"/>
  <result pre="studied animal coronavirus resulting in respiratory, enteric, hepatic and neurological" exact="infections" post="and is also a useful disease model [16]. For"/>
  <result pre="enteric, hepatic and neurological infections and is also a useful" exact="disease" post="model [16]. For instance, MHV-1 causes severe respiratory infections"/>
  <result pre="a useful disease model [16]. For instance, MHV-1 causes severe" exact="respiratory" post="infections in A/J and C3H/HeI mice. A59 and MHV-3"/>
  <result pre="useful disease model [16]. For instance, MHV-1 causes severe respiratory" exact="infections" post="in A/J and C3H/HeI mice. A59 and MHV-3 are"/>
  <result pre="causes severe encephalitis. Interestingly, A59 and an attenuated JHMV cause" exact="chronic" post="demyelinating disease in mice, which resembles multiple sclerosis (MS),"/>
  <result pre="severe encephalitis. Interestingly, A59 and an attenuated JHMV cause chronic" exact="demyelinating disease" post="in mice, which resembles multiple sclerosis (MS), providing a"/>
  <result pre="encephalitis. Interestingly, A59 and an attenuated JHMV cause chronic demyelinating" exact="disease" post="in mice, which resembles multiple sclerosis (MS), providing a"/>
  <result pre="attenuated JHMV cause chronic demyelinating disease in mice, which resembles" exact="multiple sclerosis" post="(MS), providing a mouse model for MS [17]. Another"/>
  <result pre="coronaviruses, it was thought that they caused only mild self-limiting" exact="infections" post="until the SARS-CoV outbreak in 2002â€&quot;2003 [2]. Two human"/>
  <result pre="as endemic in human populations, responsible for 15%â€&quot;30% of annual" exact="respiratory" post="tract infections [18,20]. However, a more severe disease has"/>
  <result pre="in human populations, responsible for 15%â€&quot;30% of annual respiratory tract" exact="infections" post="[18,20]. However, a more severe disease has been detected"/>
  <result pre="of annual respiratory tract infections [18,20]. However, a more severe" exact="disease" post="has been detected in neonates, elderly people and in"/>
  <result pre="with pre-existing illnesses. Moreover, HCoV-NL63 has also been associated with" exact="acute" post="laryngotracheitis [19]. Interestingly, human coronaviruses differ in genetic variability,"/>
  <result pre="pre-existing illnesses. Moreover, HCoV-NL63 has also been associated with acute" exact="laryngotracheitis" post="[19]. Interestingly, human coronaviruses differ in genetic variability, as"/>
  <result pre="As mentioned above, although MHV possesses the ability to cause" exact="demyelinating disease," post="no evidence exists of human coronaviruses being associated with"/>
  <result pre="Middle East in 2012, causing a series of highly pathogenic" exact="respiratory" post="tract infections in Saudi Arabia and other Middle East"/>
  <result pre="in 2012, causing a series of highly pathogenic respiratory tract" exact="infections" post="in Saudi Arabia and other Middle East countries [29]."/>
  <result pre="in bats, although dromedary camels have been indicated as an" exact="intermediate" post="host [33]. Moreover, it was demonstrated that MERS-CoV replicated"/>
  <result pre="an adenoviral vector [37]. The current 2019-nCoV, officially called severe" exact="acute" post="respiratory virus-coronavirus-2 (SARS-CoV-2) was first detected in the city"/>
  <result pre="adenoviral vector [37]. The current 2019-nCoV, officially called severe acute" exact="respiratory" post="virus-coronavirus-2 (SARS-CoV-2) was first detected in the city of"/>
  <result pre="market in Wuhan and spread by person-to-person transmission, causing the" exact="disease" post="named COVID-19, with various degrees of severity, from mild"/>
  <result pre="with various degrees of severity, from mild flu-like symptoms to" exact="pneumonia" post="and death [39]. Bats, snakes and pangolins are potential"/>
  <result pre="Moreover, vaccine development involves different alternatives including epitope-based peptide vaccines," exact="viral" post="vector-based vaccines and the support of bioinformatics and immunoinformatics"/>
  <result pre="considered non-essential for replication, they play an important role in" exact="viral" post="pathogenesis [43]. The virion structure has been studied by"/>
  <result pre="C-terminal RNA-binding domain facilitating the packaging of the genome into" exact="viral" post="particles [49]. The M protein containing three transmembrane domains"/>
  <result pre="of the S protein-mediated cell entry and spread through the" exact="mucosa" post="[59] as well as increase of the neurovirulence of"/>
  <result pre="proteins, replication and transcription, and assembly and release of mature" exact="viral" post="particles (Figure 2). The initial attachment occurs between the"/>
  <result pre="the plasma membrane, which leads to the release of the" exact="viral" post="genome into the cytoplasm [66,67]. The translation of the"/>
  <result pre="[2]. Following the translation and assembly of the replicase complex," exact="viral" post="RNA synthesis from both genomic and subgenomic RNAs occurs."/>
  <result pre="cis-acting sequences such as stemâ€&quot;loop structures, which are important for" exact="viral" post="RNA replication [70,71,72,73]. An interesting feature of coronavirus replication"/>
  <result pre="the 5â€² end [74,75]. In the context of assembly, the" exact="viral" post="structural proteins S, E, and M are translated and"/>
  <result pre="secretory pathways into the endoplasmic reticulum (ER) and the ERâ€&quot;Golgi" exact="intermediate" post="compartment (ERGIC) [76,77]. At the ERGIC, viral genomes surrounded"/>
  <result pre="and the ERâ€&quot;Golgi intermediate compartment (ERGIC) [76,77]. At the ERGIC," exact="viral" post="genomes surrounded by N protein participate in the formation"/>
  <result pre="understanding of individual coronaviruses. Other options include monoclonal antibodies and" exact="viral" post="receptor blockers [81]. Products developed as Chinese traditional medicines"/>
  <result pre="therapy with other antiretroviral agents for the treatment of HIV-1" exact="infections" post="has provided durable virologic suppression and improved immunological outcomes"/>
  <result pre="Lopinavir/ritonavir combination treatment was evaluated in marmosets with a MERS-like" exact="disease" post="[85]. In comparison to mycophenolate mofetil (MFF), the treatment"/>
  <result pre="the treatment showed improved clinical, radiological and pathological outcomes and" exact="lower" post="mean viral loads in necropsied lung and extrapulmonary tissues,"/>
  <result pre="showed improved clinical, radiological and pathological outcomes and lower mean" exact="viral" post="loads in necropsied lung and extrapulmonary tissues, whereas MFF-treated"/>
  <result pre="results, a study protocol for a clinical trial for hospitalized" exact="adult" post="MERS patients was prepared [86]. The goal is to"/>
  <result pre="care. However, no difference in clinical improvement, mortality or detectable" exact="viral" post="RNA was obtained [87]. In a modified intention-to-treat analysis,"/>
  <result pre="acting as an alternative substrate and RNA chain terminator of" exact="viral" post="RdRp was non-toxic and effectively inhibited FIPV replication in"/>
  <result pre="alternative substrate and RNA chain terminator of viral RdRp was" exact="non-toxic" post="and effectively inhibited FIPV replication in feline CRFK cells"/>
  <result pre="all ten cats treated with GS-441524 showed rapid reversal of" exact="disease" post="symptoms in two weeks. In another approach, the guanosine"/>
  <result pre="the guanosine analogue ribavirin was administered together with interferon-Î±2a in" exact="adult" post="patients with laboratory-confirmed MERS-CoV infection and pneumonia needing ventilation"/>
  <result pre="administered together with interferon-Î±2a in adult patients with laboratory-confirmed MERS-CoV" exact="infection" post="and pneumonia needing ventilation support [92]. The study demonstrated"/>
  <result pre="with interferon-Î±2a in adult patients with laboratory-confirmed MERS-CoV infection and" exact="pneumonia" post="needing ventilation support [92]. The study demonstrated that patients"/>
  <result pre="effectively inhibited SARS-CoV-2 in Vero cells and in human Huh-7" exact="liver cancer" post="cells known to be susceptible to SARS-CoV-2 [96]. The"/>
  <result pre="inhibited SARS-CoV-2 in Vero cells and in human Huh-7 liver" exact="cancer" post="cells known to be susceptible to SARS-CoV-2 [96]. The"/>
  <result pre="to improvement in the patientâ€™s condition with a decline in" exact="viral" post="load [97]. Neuraminidase inhibitors such as zanamivir, laninamivir, oseltamivir"/>
  <result pre="effect against Zika virus (ZIKV), West Nile virus (WNV) and" exact="tick-borne encephalitis" post="virus (TBEV) has been demonstrated in Vero cells [100]."/>
  <result pre="against Zika virus (ZIKV), West Nile virus (WNV) and tick-borne" exact="encephalitis" post="virus (TBEV) has been demonstrated in Vero cells [100]."/>
  <result pre="the monotherapy. biomedicines-08-00109-t002_Table 2Table 2 Therapeutic interventions against coronaviruses. Therapy" exact="Disease" post="Effect Ref. Lopinavir/Ritonavir MERS-like in marmosets Clinical, pathological benefits"/>
  <result pre="inhibition [95] SARS-CoV-2 Inhibition in Vero, Huh-7 cells [96] SARS-CoV-2" exact="Reduced" post="viral load in patients [97] NA inhibitors SARS-CoV No"/>
  <result pre="[95] SARS-CoV-2 Inhibition in Vero, Huh-7 cells [96] SARS-CoV-2 Reduced" exact="viral" post="load in patients [97] NA inhibitors SARS-CoV No inhibitory"/>
  <result pre="SARS-CoV-2 Positive effect in patients with lopinavir/ritonavir [102] Hydroxychloroquinine SARS-CoV-2" exact="Reduced" post="viral load in 20 COVID-19 patients [103] Chinese medicines"/>
  <result pre="Positive effect in patients with lopinavir/ritonavir [102] Hydroxychloroquinine SARS-CoV-2 Reduced" exact="viral" post="load in 20 COVID-19 patients [103] Chinese medicines SARS-CoV-2"/>
  <result pre="SARS-CoV-2 [109] ACE2, angiotensin-converting enzyme 2; CoV, coronavirus; FIP, feline" exact="infectious" post="peritonitis; HCoV, human coronavirus; MERS, Middle East respiratory syndrome;"/>
  <result pre="FIP, feline infectious peritonitis; HCoV, human coronavirus; MERS, Middle East" exact="respiratory" post="syndrome; NA, neuraminidase; nABs, neutralizing antibodies; mAbs, monoclonal antibodies;"/>
  <result pre="NA, neuraminidase; nABs, neutralizing antibodies; mAbs, monoclonal antibodies; SARS-CoV, severe" exact="acute" post="respiratory syndrome-coronavirus; SHL, Shuanghuanglian oral liquid; SJ, Shufeng Jiedu;"/>
  <result pre="neuraminidase; nABs, neutralizing antibodies; mAbs, monoclonal antibodies; SARS-CoV, severe acute" exact="respiratory" post="syndrome-coronavirus; SHL, Shuanghuanglian oral liquid; SJ, Shufeng Jiedu; TMPRSS2,"/>
  <result pre="potential therapeutic effect of the widely used antimalarial and auto-immune" exact="disease" post="drug chloroquine on coronaviruses [96]. Chloroquine blocks virus infection"/>
  <result pre="and auto-immune disease drug chloroquine on coronaviruses [96]. Chloroquine blocks" exact="virus infection" post="and interferes with the glycosylation of cellular receptors of"/>
  <result pre="auto-immune disease drug chloroquine on coronaviruses [96]. Chloroquine blocks virus" exact="infection" post="and interferes with the glycosylation of cellular receptors of"/>
  <result pre="a safer clinical profile, should be considered [112]. In a" exact="limited" post="clinical trial, 20 French COVID-19 patients were treated with"/>
  <result pre="were treated with hydroxychloroquine, resulting in a significant reduction in" exact="viral" post="load in comparison to control patients [103]. Addition of"/>
  <result pre="study indicated that hydroxychloroquine treatment was associated with a significant" exact="viral" post="load reduction and disappearance of COVID-19. However, the trial"/>
  <result pre="dropped out and the assessment of efficacy was based on" exact="viral" post="load, which was not a clinical endpoint. Additional studies"/>
  <result pre="from COVID-19 has been reported [104]. Case 1, a 51-year-old" exact="female" post="with high fever diagnosed with COVID-19 was confined into"/>
  <result pre="In another study, four patients with mild or severe 2019-nCoV" exact="pneumonia" post="were treated with lopinavir/ritonavir, arbidol and traditional Chinese medicine"/>
  <result pre="capsules [105]. Three patients showed significant improvement related to the" exact="pneumonia" post="symptoms and tested 2019-nCoV negative, and one patient with"/>
  <result pre="symptoms and tested 2019-nCoV negative, and one patient with severe" exact="pneumonia" post="also showed improvement. Another potential approach for COVID-19 treatment"/>
  <result pre="has demonstrated immunostimulation in humans infected by WNV, influenza virus," exact="avian influenza" post="virus, hepatitis C virus, papilloma virus, herpes virus, hepatitis"/>
  <result pre="in humans infected by WNV, influenza virus, avian influenza virus," exact="hepatitis C" post="virus, papilloma virus, herpes virus, hepatitis B virus and"/>
  <result pre="by WNV, influenza virus, avian influenza virus, hepatitis C virus," exact="papilloma" post="virus, herpes virus, hepatitis B virus and HIV [113]."/>
  <result pre="influenza virus, avian influenza virus, hepatitis C virus, papilloma virus," exact="herpes" post="virus, hepatitis B virus and HIV [113]. Although the"/>
  <result pre="avian influenza virus, hepatitis C virus, papilloma virus, herpes virus," exact="hepatitis" post="B virus and HIV [113]. Although the potency of"/>
  <result pre="proven to be efficient for the prevention and treatment of" exact="respiratory" post="infections caused by influenza A [114] but have not"/>
  <result pre="to be efficient for the prevention and treatment of respiratory" exact="infections" post="caused by influenza A [114] but have not yet"/>
  <result pre="blockers such as losartan, commonly used for the treatment of" exact="hypertension" post="[108], for a reduction in aggressiveness and mortality from"/>
  <result pre="[108], for a reduction in aggressiveness and mortality from SARS-CoV-2" exact="infections" post="[115]. The approach is based on the finding that"/>
  <result pre="subjected to several gene silencing studies (Table 3). For instance," exact="short" post="interfering RNAs (siRNAs) have been demonstrated to efficiently inhibit"/>
  <result pre="into fetal rhesus kidney FRhK4 cells before or after SARS-CoV" exact="infection" post="and the inhibitory effects were verified by the decrease"/>
  <result pre="the inhibitory effects were verified by the decrease in intracellular" exact="viral" post="genome copy number and viral titers. Four siRNAs demonstrated"/>
  <result pre="by the decrease in intracellular viral genome copy number and" exact="viral" post="titers. Four siRNAs demonstrated potent inhibition of SARS-CoV infection"/>
  <result pre="and viral titers. Four siRNAs demonstrated potent inhibition of SARS-CoV" exact="infection" post="and replication. Prophylactic effects with up to 90% inhibition"/>
  <result pre="h. Combination of siRNA duplexes from different regions of the" exact="viral" post="genome provided up to 80% inhibition. Furthermore, siRNA duplexes"/>
  <result pre="in Vero cells [122]. It was further demonstrated that SARS-CoV" exact="infection" post="was reduced in ACE2-silenced cell lines, providing an attractive"/>
  <result pre="with the SARS-CoV spike protein during the entry stage of" exact="infection" post="[123]. In the context of MERS-CoV the ORF1ab region"/>
  <result pre="region encoding the replicase polyproteins plays a vital role in" exact="viral infection" post="and therefore represents a suitable target for disease control."/>
  <result pre="encoding the replicase polyproteins plays a vital role in viral" exact="infection" post="and therefore represents a suitable target for disease control."/>
  <result pre="in viral infection and therefore represents a suitable target for" exact="disease" post="control. Four miRNA and five siRNA molecules were rationally"/>
  <result pre="attempts to optimize delivery of MERS-CoV siRNAs, transfection, electroporation and" exact="viral" post="gene transfers have been applied. Recently, advanced nanotechnology based"/>
  <result pre="To address the problem, combination therapy with three siRNAs prevented" exact="viral" post="escape over the course of five passages [125]. Moreover,"/>
  <result pre="for FIPV. In the context of porcine deltacoronavirus (PDCoV), two" exact="short" post="hairpin RNA (shRNA)-expressing plasmids targeting the M (pGenesil-M) and"/>
  <result pre="titer reduction, respectively, and a 45.8% and 56.1% decrease in" exact="viral" post="RNA, respectively. In another study, shRNAs targeting the M"/>
  <result pre="another study, shRNAs targeting the M gene of porcine epidemic" exact="diarrhea" post="virus (PEDV) and swine acute diarrhea syndrome coronavirus (SADS-CoV)"/>
  <result pre="M gene of porcine epidemic diarrhea virus (PEDV) and swine" exact="acute" post="diarrhea syndrome coronavirus (SADS-CoV) and the N gene of"/>
  <result pre="gene of porcine epidemic diarrhea virus (PEDV) and swine acute" exact="diarrhea" post="syndrome coronavirus (SADS-CoV) and the N gene of PDCoV"/>
  <result pre="of porcine epidemic diarrhea virus (PEDV) and swine acute diarrhea" exact="syndrome" post="coronavirus (SADS-CoV) and the N gene of PDCoV inhibited"/>
  <result pre="and the N gene of PDCoV inhibited expression of each" exact="viral" post="RNA over 98% [127]. Moreover, shRNAs significantly restricted the"/>
  <result pre="3.3. Vaccine Development The classic approach for vaccine development against" exact="viral" post="diseases has involved immunization with live attenuated or inactivated"/>
  <result pre="vaccine against BCoV was developed by progressive attenuation of the" exact="respiratory" post="BCoV strain 438/06-TN [131]. The vaccine was proven safe"/>
  <result pre="post-vaccination. The intranasal drug BovilisÂ® has been approved against enteric" exact="disease" post="caused by BCoV in young calves [132]. The lack"/>
  <result pre="ECoV in horses after vaccination with the BCoV vaccine [133]." exact="Antibody" post="titers against ECoV increased in all six vaccinated horses"/>
  <result pre="vaccinated horses at 14 days post-inoculation, although the titers were" exact="lower" post="against ECoV than BCoV, and it remained unclear whether"/>
  <result pre="potent CTL and HTL epitopes and adjuvants were linked by" exact="short" post="peptide molecular linkers. Tertiary models for both multi-epitope vaccines"/>
  <result pre="G2, which targets the MERS-CoV N-terminal domain of S1 [138]." exact="Structural" post="and functional characterization of G2 alone or complexed with"/>
  <result pre="3.4 Ã… resolution of the spike glycoprotein trimer essential for" exact="viral" post="entry into host cells and representing the main target"/>
  <result pre="domains involved in the anchoring of the trimer to the" exact="viral" post="membrane. The study also revealed that HCoV-NL63 use molecular"/>
  <result pre="trimer for the identification of potential targets for vaccines and" exact="viral" post="entry inhibition as the furin cleavage site between the"/>
  <result pre="global coverage. biomedicines-08-00109-t004_Table 4Table 4 Vaccine approaches against voronaviruses. Vaccine/Vector" exact="Disease" post="Effect Ref. Live attenuated BCoV High Ab titers against"/>
  <result pre="BCoV Approved nasal vaccine in calves [132] BCoV vaccine ECoV" exact="Increased" post="Ab titers against ECoV [133] Plasmid DNA SARS-CoV Humoral"/>
  <result pre="responses in mice after intranasal administration [143] TCoV Humoral response," exact="partial" post="TCoV protection [144] DNA + protein TGEV Oral administration"/>
  <result pre="PEDV Immune response in mice and piglets [150] Ad-LTB-COE MERS-CoV" exact="Reduced" post="viral excretion and viral RNA in dromedary camels [151]"/>
  <result pre="Immune response in mice and piglets [150] Ad-LTB-COE MERS-CoV Reduced" exact="viral" post="excretion and viral RNA in dromedary camels [151] MVA-MERS-CoV"/>
  <result pre="mice and piglets [150] Ad-LTB-COE MERS-CoV Reduced viral excretion and" exact="viral" post="RNA in dromedary camels [151] MVA-MERS-CoV S MERS-CoV Identification"/>
  <result pre="from Mason-Pfizer monkey virus; ECoV, equine coronavirus; MERS-CoV, Middle East" exact="respiratory" post="syndrome-coronavirus; MVA, Modified vaccinia virus Ankara; P19 TBSV, gene"/>
  <result pre="ECoV, equine coronavirus; MERS-CoV, Middle East respiratory syndrome-coronavirus; MVA, Modified" exact="vaccinia" post="virus Ankara; P19 TBSV, gene silencing suppressor P19 protein"/>
  <result pre="P19 protein from tomato bushy stunt virus; PEDV, porcine epidemic" exact="diarrhea" post="virus; PEI, polyethylenimine; PRE, post-transcriptional regulatory element from Woodchuck"/>
  <result pre="diarrhea virus; PEI, polyethylenimine; PRE, post-transcriptional regulatory element from Woodchuck" exact="hepatitis" post="virus; nABs, neutralizing antibodies; NPs, nanoparticles; S377-588, RV, rabies"/>
  <result pre="Woodchuck hepatitis virus; nABs, neutralizing antibodies; NPs, nanoparticles; S377-588, RV," exact="rabies" post="virus; SARS-CoV, severe acute respiratory syndrome-coronavirus, TCoV, turkey coronavirus;"/>
  <result pre="neutralizing antibodies; NPs, nanoparticles; S377-588, RV, rabies virus; SARS-CoV, severe" exact="acute" post="respiratory syndrome-coronavirus, TCoV, turkey coronavirus; TGEV, transmissible gastroenteritis virus."/>
  <result pre="antibodies; NPs, nanoparticles; S377-588, RV, rabies virus; SARS-CoV, severe acute" exact="respiratory" post="syndrome-coronavirus, TCoV, turkey coronavirus; TGEV, transmissible gastroenteritis virus. Nucleic"/>
  <result pre="SARS-CoV, severe acute respiratory syndrome-coronavirus, TCoV, turkey coronavirus; TGEV, transmissible" exact="gastroenteritis" post="virus. Nucleic acid-based vaccines have become attractive alternatives to"/>
  <result pre="DNA vector containing donor and acceptor splice sites and heterologous" exact="viral" post="RNA export elements such as the constitutive transport element"/>
  <result pre="post-transcriptional regulatory element (PRE) from Mason-Pfizer monkey virus and Woodchuck" exact="hepatitis" post="virus, respectively [142]. These vector modifications significantly improved the"/>
  <result pre="with 200 Î¼g of 4F/4R fragment. Animals were challenged with" exact="infectious" post="TCoV and clinical signs were monitored by an immunofluorescence"/>
  <result pre="antibody assay. Immunized turkeys showed less clinical signs and a" exact="lower" post="viral load compared to control animals. The vaccination also"/>
  <result pre="assay. Immunized turkeys showed less clinical signs and a lower" exact="viral" post="load compared to control animals. The vaccination also induced"/>
  <result pre="animals. The vaccination also induced humoral immune responses and provided" exact="partial" post="protection against challenges with TCoV. Cellular and viral vector-based"/>
  <result pre="and provided partial protection against challenges with TCoV. Cellular and" exact="viral" post="vector-based expression systems play an important role in vaccine"/>
  <result pre="size of the CoV genome has complicated the construction of" exact="infectious" post="clones for utilization in studies on basic viral processes"/>
  <result pre="construction of infectious clones for utilization in studies on basic" exact="viral" post="processes and development of genetically defined vaccines [156]. In"/>
  <result pre="and development of genetically defined vaccines [156]. In this context," exact="bacterial" post="artificial chromosomes (BACs) can provide a robust system for"/>
  <result pre="chromosomes (BACs) can provide a robust system for expression of" exact="viral" post="RNA in the nucleus under the control of a"/>
  <result pre="a cytomegalovirus (CMV) promoter followed by RNA amplification by the" exact="viral" post="replicase in the cytoplasm [157]. In a prokaryotic approach,"/>
  <result pre="both mucosal and humoral immune responses. In another approach, a" exact="stable" post="CHO cell line was engineered to express a subunit"/>
  <result pre="can provide protection against MERS-CoV challenges in vaccinated animals. For" exact="stable" post="expression, the IL-2 signal peptide was introduced in front"/>
  <result pre="that the S1-GFP fusion protein was expressed in the cytoplasm." exact="Stable" post="expression from the cauliflower mosaic virus 35S promoter resulted"/>
  <result pre="tomato and low-nicotine tobacco plants [148]. The plant-derived antigen elicited" exact="systemic" post="and mucosal immune responses in mice. Significantly increased levels"/>
  <result pre="of plant-based expression systems for rapid vaccine development against SARS-CoV-2." exact="Viral" post="vectors have been frequently used as delivery vehicles for"/>
  <result pre="have been frequently used as delivery vehicles for immunization against" exact="infectious" post="agents such as pathogenic viruses [159]. In many cases,"/>
  <result pre="with highly virulent PEDV strains. In another study, the modified" exact="vaccinia" post="virus Ankara (MVA) strain was utilized for the expression"/>
  <result pre="elicited mucosal immunity. Immunized camels showed significantly reduced excretion of" exact="infectious" post="virus and viral RNA transcripts and protection against MERS-CoV"/>
  <result pre="Immunized camels showed significantly reduced excretion of infectious virus and" exact="viral" post="RNA transcripts and protection against MERS-CoV correlated with the"/>
  <result pre="G and polymerase L genes in a highly attenuated safe" exact="rabies" post="virus (RV) vector [153]. A single injection with the"/>
  <result pre="DNA plasmids or synthetic mRNA molecules are 100- to 1000-fold" exact="lower" post="[160]. In the context of coronaviruses, Venezuelan equine encephalitis"/>
  <result pre="100- to 1000-fold lower [160]. In the context of coronaviruses," exact="Venezuelan equine encephalitis" post="virus (VEE) replicon particles were used for the expression"/>
  <result pre="1000-fold lower [160]. In the context of coronaviruses, Venezuelan equine" exact="encephalitis" post="virus (VEE) replicon particles were used for the expression"/>
  <result pre="that VEE particles expressing SARS-CoV S but not N provided" exact="complete" post="short- and long-term protection against challenges with homologous strains"/>
  <result pre="strain. However, immunization with VEE particles expressing SARS-CoV S provided" exact="complete" post="short-term protection against challenges with icGDO3-S in young mice,"/>
  <result pre="vaccine development, antibody-dependent enhancement (ADE) comprises an important mechanism facilitating" exact="viral" post="cell entry, in which virions are complexed with antibodies,"/>
  <result pre="in which virions are complexed with antibodies, resulting in enhanced" exact="viral" post="replication [161]. In the context of COVID-19, prior infection"/>
  <result pre="enhanced viral replication [161]. In the context of COVID-19, prior" exact="infection" post="with other coronaviruses, from common cold to SARS-CoV, may"/>
  <result pre="cold to SARS-CoV, may have primed COVID-19 patients, causing severe" exact="disease" post="once infected with SARS-CoV-2. This could explain the discrepancy"/>
  <result pre="SARS-CoV-2. This could explain the discrepancy between the severity of" exact="disease" post="in COVID-19 patients in the Hubei province in China"/>
  <result pre="can trigger a conformational change of the S protein mediating" exact="viral" post="entry via IgG Fc cellular receptors [163]. Another issue"/>
  <result pre="receptors [163]. Another issue related to vaccine development comprises the" exact="type II" post="cellular immunity for lung pathogenicity. In this context, accumulated"/>
  <result pre="pathogen infection. In contrast, inefficient immune responses can trigger various" exact="pulmonary" post="diseases. Related to SARS and COVID-19 lung pathology, recovery"/>
  <result pre="SARS and COVID-19 lung pathology, recovery requires rigorous innate and" exact="acquired" post="immune responses and epithelial regeneration [165]. However, administration of"/>
  <result pre="pathology, recovery requires rigorous innate and acquired immune responses and" exact="epithelial" post="regeneration [165]. However, administration of epithelial growth factors such"/>
  <result pre="acquired immune responses and epithelial regeneration [165]. However, administration of" exact="epithelial" post="growth factors such as the keratinocyte growth factor (KGF)"/>
  <result pre="(KGF) might stimulate the production of ACE2-expressing cells, increasing the" exact="viral" post="load. An immunotherapeutic approach of great interest relates to"/>
  <result pre="In another case study, five critically ill COVID-19 patients with" exact="acute" post="respiratory distress syndrome (ARDS) were treated with convalescent plasma"/>
  <result pre="another case study, five critically ill COVID-19 patients with acute" exact="respiratory" post="distress syndrome (ARDS) were treated with convalescent plasma obtained"/>
  <result pre="study, five critically ill COVID-19 patients with acute respiratory distress" exact="syndrome" post="(ARDS) were treated with convalescent plasma obtained from patients"/>
  <result pre="showed a normalized body temperature within 3â€&quot;4 days and their" exact="viral" post="load decreased and became negative within 12 days. Moreover,"/>
  <result pre="from the hospital and the two remaining patients were in" exact="stable" post="condition. Obviously, the limited number of patients and study"/>
  <result pre="the two remaining patients were in stable condition. Obviously, the" exact="limited" post="number of patients and study design do not permit"/>
  <result pre="antiviral drugs in the form of existing drugs for other" exact="viral" post="diseases, which should be subjected to thorough well-planned clinical"/>
  <result pre="on in vitro studies, animal models or experiences from other" exact="viral" post="diseases [172]. For instance, a Chinese trial in more"/>
  <result pre="of chloroquine phosphate compared to control treatment in inhibition of" exact="pneumonia" post="exacerbation [173]. Moreover, in a placebo-controlled randomized trial of"/>
  <result pre="for the higher dose [174]. However, the results from the" exact="lower" post="dose were not described, the endpoints specified in the"/>
  <result pre="the drug. However, hydroxychloroquine will potentially expose patients to serious" exact="cutaneous" post="adverse reactions [176], hepatic failure [177] and ventricular arrhythmias"/>
  <result pre="clinical improvement compared to the standard-care control group [87]. Detectable" exact="viral" post="RNA levels and mortality numbers were similar for the"/>
  <result pre="The Efficacy of Lopinavir Plus Ritonavir and Arbidol against Coronavirus" exact="Infection" post="(ELACOI) single-blind randomized controlled trial in China included 44"/>
  <result pre="seen after lopinavir/ritonavir treatment. Overall, although drugs developed for other" exact="infectious diseases" post="might provide alternative treatment strategies for COVID-19 when evaluated"/>
  <result pre="utilization of purified epitope peptides and antigens and cellular or" exact="viral" post="delivery systems should all be explored in parallel to"/>
  <result pre="all possible means of delivery including mRNA, plasmid DNA, non-replicating" exact="viral" post="vectors, inactivated and live attenuated virus and protein subunits."/>
  <result pre="of coronavirus drugs and vaccines. Funding This research received no" exact="external" post="funding. Conflicts of Interest The author declares no conflict"/>
  <result pre="Overview of Their Replication and PathogenesisMethods Mol. Biol.2015128212325720466 3.DoyleL.P.HutchingsL.M.A transmissible" exact="gastroenteritis" post="in pigsJ. Am. Vet. Med. Assoc.194610825725921020443 4.LinC.M.SaifL.J.MarthalerD.WangQ.Evolution, antigenicity and"/>
  <result pre="Vet. Med. Assoc.194610825725921020443 4.LinC.M.SaifL.J.MarthalerD.WangQ.Evolution, antigenicity and pathogenicity of porcine epidemic" exact="diarrhea" post="virusVirus Res.2016226203910.1016/j.virusres.2016.05.02327288724 5.Mora-DÃ­azJ.C.PiÃ±eyroP.E.HoustonE.ZimmermanJ.GimÃ©nez-LirolaL.G.Porcine Hemagglutinating Encephalomyelitis Virus: A ReviewFront. Vet."/>
  <result pre="7.PerlmanS.NetlandJ.Coronaviruses post-SARS: Update on replication and pathogenesisNat. Rev. Microbiol.2009743945010.1038/nrmicro214719430490 8.FunkC.J.ManzerR.MiuraT.A.GroshongS.D.ItoY.TravantyE.A.LeeteJ.HolmesK.V.MasonR.J.Rat" exact="respiratory" post="coronavirus infection: Replication in airway and alveolar epithelial cells"/>
  <result pre="Microbiol.2009743945010.1038/nrmicro214719430490 8.FunkC.J.ManzerR.MiuraT.A.GroshongS.D.ItoY.TravantyE.A.LeeteJ.HolmesK.V.MasonR.J.Rat respiratory coronavirus infection: Replication in airway and alveolar" exact="epithelial" post="cells and the innate immune responseJ. Gen. Virol.2009902956296410.1099/vir.0.014282-019741068 9.CavanaghD.Coronavirus"/>
  <result pre="cells and the innate immune responseJ. Gen. Virol.2009902956296410.1099/vir.0.014282-019741068 9.CavanaghD.Coronavirus avian" exact="infectious" post="bronchitis virusVet. Res.20073828129710.1051/vetres:200605517296157 10.WolfeL.G.GriesemerR.A.Feline infectious peritonitisPathol. Vet.1966325527010.1177/0300985866003003095958991 11.JaimesJ.A.WhittakerG.A.Feline coronavirus:"/>
  <result pre="and the innate immune responseJ. Gen. Virol.2009902956296410.1099/vir.0.014282-019741068 9.CavanaghD.Coronavirus avian infectious" exact="bronchitis" post="virusVet. Res.20073828129710.1051/vetres:200605517296157 10.WolfeL.G.GriesemerR.A.Feline infectious peritonitisPathol. Vet.1966325527010.1177/0300985866003003095958991 11.JaimesJ.A.WhittakerG.A.Feline coronavirus: Insights"/>
  <result pre="responseJ. Gen. Virol.2009902956296410.1099/vir.0.014282-019741068 9.CavanaghD.Coronavirus avian infectious bronchitis virusVet. Res.20073828129710.1051/vetres:200605517296157 10.WolfeL.G.GriesemerR.A.Feline" exact="infectious" post="peritonitisPathol. Vet.1966325527010.1177/0300985866003003095958991 11.JaimesJ.A.WhittakerG.A.Feline coronavirus: Insights into viral pathogenesis based"/>
  <result pre="virusVet. Res.20073828129710.1051/vetres:200605517296157 10.WolfeL.G.GriesemerR.A.Feline infectious peritonitisPathol. Vet.1966325527010.1177/0300985866003003095958991 11.JaimesJ.A.WhittakerG.A.Feline coronavirus: Insights into" exact="viral" post="pathogenesis based on the spike protein structure and functionVirology201851710812110.1016/j.virol.2017.12.02729329682"/>
  <result pre="of diverse alphacoronaviruses and genomic characterization of a novel severe" exact="acute" post="respiratory syndrome-like coronavirus from bats in chinaJ. Virol.2014887070708210.1128/JVI.00631-1424719429 15.MenacheryV.D.YontB.L.Jr.DebbinkK.AgnihothramS.GralinskiL.E.PlanteJ.A.GrahamR.L.ScobeyT.GeX.Y.DonaldsonE.F.et"/>
  <result pre="diverse alphacoronaviruses and genomic characterization of a novel severe acute" exact="respiratory" post="syndrome-like coronavirus from bats in chinaJ. Virol.2014887070708210.1128/JVI.00631-1424719429 15.MenacheryV.D.YontB.L.Jr.DebbinkK.AgnihothramS.GralinskiL.E.PlanteJ.A.GrahamR.L.ScobeyT.GeX.Y.DonaldsonE.F.et al.A"/>
  <result pre="in JHM virus encephalomyelitisActa Neuropathol.197324768510.1007/BF006914214349379 18.BradburneA.F.BynoeM.L.TyrellD.A.J.Effects of a â€œnewâ€� human" exact="respiratory" post="virus in volunteersBr. Med. J.1967376776910.1136/bmj.3.5568.7676043624 19.van der HoekL.SureK.IhorstG.StangA.PyrcK.JebbinkM.F.PetersenG.ForsterJ.BerkhoutB.UberlaK.Croup is"/>
  <result pre="coronavirus NL63PLoS Med.20052e24010.1371/journal.pmed.002024016104827 20.HamreD.ProcknowJ.J.A new virus isolated from the human" exact="respiratory" post="tractProc. Soc. Exp. Biol. Med.196612119019310.3181/00379727-121-307344285768 21.AndersonR.M.FraserC.GhaniA.C.DonellyC.A.RileyS.FergusonN.M.LeungG.M.LamT.H.HedleyA.J.Epidemiology, transmission dynamics and"/>
  <result pre="mini pandemicPaediatr. Resp. Rev.2004526226910.1016/j.prrv.2004.07.00915531249 23.AleaniziF.S.MohmedN.AlqahtaniF.Y.El Hadi MohamedR.A.Outbreak of Middle east" exact="respiratory" post="syndrome coronavirus in Saudi Arabia: A retrospective studyBMC Infect."/>
  <result pre="pandemicPaediatr. Resp. Rev.2004526226910.1016/j.prrv.2004.07.00915531249 23.AleaniziF.S.MohmedN.AlqahtaniF.Y.El Hadi MohamedR.A.Outbreak of Middle east respiratory" exact="syndrome" post="coronavirus in Saudi Arabia: A retrospective studyBMC Infect. Dis.2017172310.1186/s12879-016-2137-328056850"/>
  <result pre="to the SARS coronavirus from animals in southern ChinaScience200330227627810.1126/science.108713912958366 25.LauS.K.WooP.C.LiK.S.HuangY.TsoiH.W.WongB.H.WongS.S.LeungS.Y.ChanK.H.YuenK.Y.Severe" exact="acute" post="respiratory syndrome coronavirus-like virus in Chinese horseshoe batsProc. Natl."/>
  <result pre="the SARS coronavirus from animals in southern ChinaScience200330227627810.1126/science.108713912958366 25.LauS.K.WooP.C.LiK.S.HuangY.TsoiH.W.WongB.H.WongS.S.LeungS.Y.ChanK.H.YuenK.Y.Severe acute" exact="respiratory" post="syndrome coronavirus-like virus in Chinese horseshoe batsProc. Natl. Acad."/>
  <result pre="SARS coronavirus from animals in southern ChinaScience200330227627810.1126/science.108713912958366 25.LauS.K.WooP.C.LiK.S.HuangY.TsoiH.W.WongB.H.WongS.S.LeungS.Y.ChanK.H.YuenK.Y.Severe acute respiratory" exact="syndrome" post="coronavirus-like virus in Chinese horseshoe batsProc. Natl. Acad. Sci."/>
  <result pre="bat SARS-like coronavirus that uses the ACE2 receptorNature201350353553810.1038/nature1271124172901 28.PeirisJ.S.YuenK.Y.OsterhausA.D.StohrK.The severe" exact="acute" post="respiratory syndromeN. Engl. J. Med.20033492431244110.1056/NEJMra03249814681510 29.ZakiA.M.van BoheemenS.BestebroerT.M.OsterhausA.D.FouchierR.A.Isolation of a"/>
  <result pre="SARS-like coronavirus that uses the ACE2 receptorNature201350353553810.1038/nature1271124172901 28.PeirisJ.S.YuenK.Y.OsterhausA.D.StohrK.The severe acute" exact="respiratory" post="syndromeN. Engl. J. Med.20033492431244110.1056/NEJMra03249814681510 29.ZakiA.M.van BoheemenS.BestebroerT.M.OsterhausA.D.FouchierR.A.Isolation of a novel"/>
  <result pre="29.ZakiA.M.van BoheemenS.BestebroerT.M.OsterhausA.D.FouchierR.A.Isolation of a novel coronavirus from a man with" exact="pneumonia" post="in Saudi ArabiaN. Engl. J. Med.20123671814182010.1056/NEJMoa121172123075143 30.van BoheemenS.de GraafM.LauberC.BestebroerT.M.RajV.S.ZakiA.M.OsterhausA.D.HaagmansB.L.GorbalenyaA.E.SnijderE.J.et"/>
  <result pre="GraafM.LauberC.BestebroerT.M.RajV.S.ZakiA.M.OsterhausA.D.HaagmansB.L.GorbalenyaA.E.SnijderE.J.et al.Genomic characterization of a newly discovered coronavirus associated with" exact="acute" post="respiratory distress syndrome in humansmBio20123e00473-1210.1128/mBio.00473-1223170002 31.ChiboD.BirchC.Analysis of human coronavirus"/>
  <result pre="al.Genomic characterization of a newly discovered coronavirus associated with acute" exact="respiratory" post="distress syndrome in humansmBio20123e00473-1210.1128/mBio.00473-1223170002 31.ChiboD.BirchC.Analysis of human coronavirus 229E"/>
  <result pre="of a newly discovered coronavirus associated with acute respiratory distress" exact="syndrome" post="in humansmBio20123e00473-1210.1128/mBio.00473-1223170002 31.ChiboD.BirchC.Analysis of human coronavirus 229E spike and"/>
  <result pre="37.ZhaoJ.LiK.Wohlford-LenaneC.AgnihothramS.S.FettC.ZhaoJ.GaleM.J.Jr.BaricR.S.EnjuanesL.GallagherT.et al.Rapid generation of a mouse model for Middle East" exact="respiratory" post="syndromeProc. Natl. Acad. Sci. USA20141114970497510.1073/pnas.132327911124599590 38.KaplanE.H.Containing 2019-nCoV (Wuhan) coronavirusHealth"/>
  <result pre="replication and liver pathologyCell. Host Microbe20121160761610.1016/j.chom.2012.04.01122704621 44.BarcenaM.OostergetelG.T.BartelinkW.FaasF.G.VerkleijA.RottierP.J.KosterA.J.BoschB.J.Cryo-electron tomography of mouse" exact="hepatitis" post="virus: Insights into the structure of the coronavirionProc. Natl."/>
  <result pre="the coronavirionProc. Natl. Acad. Sci. USA200910658258710.1073/pnas.080527010619124777 45.NeumanB.W.AdairB.D.YoshiokaC.QuispeJ.D.OrcaG.KuhnP.MilliganR.A.YeagerM.BuchmeierM.J.Supramolecular architecture of severe" exact="acute" post="respiratory syndrome coronavirus revealed by electron cryomicroscopyJ. Virol.2006807918792810.1128/JVI.00645-0616873249 46.de"/>
  <result pre="coronavirionProc. Natl. Acad. Sci. USA200910658258710.1073/pnas.080527010619124777 45.NeumanB.W.AdairB.D.YoshiokaC.QuispeJ.D.OrcaG.KuhnP.MilliganR.A.YeagerM.BuchmeierM.J.Supramolecular architecture of severe acute" exact="respiratory" post="syndrome coronavirus revealed by electron cryomicroscopyJ. Virol.2006807918792810.1128/JVI.00645-0616873249 46.de GrootR.J.LuytjesW.HorzinekM.C.van"/>
  <result pre="Natl. Acad. Sci. USA200910658258710.1073/pnas.080527010619124777 45.NeumanB.W.AdairB.D.YoshiokaC.QuispeJ.D.OrcaG.KuhnP.MilliganR.A.YeagerM.BuchmeierM.J.Supramolecular architecture of severe acute respiratory" exact="syndrome" post="coronavirus revealed by electron cryomicroscopyJ. Virol.2006807918792810.1128/JVI.00645-0616873249 46.de GrootR.J.LuytjesW.HorzinekM.C.van der"/>
  <result pre="Virol.1988624288429510.1128/JVI.62.11.4288-4295.19882845141 48.MolenkampR.SpaanW.J.Identification of a specific interaction between the coronavirus mouse" exact="hepatitis" post="virus A59 nucleocapsid protein and packaging signalVirology1997239788610.1006/viro.1997.88679426448 49.KuoL.MastersP.S.Functional analysis"/>
  <result pre="a membrane protein that is incorporated into virionsVirology199218866667510.1016/0042-6822(92)90521-P1316677 53.Nieto-TorresJ.L.DediegoM.L.Verdia-BaguenaC.Jimenez-GuardenoJ.M.Regla-NavaJ.A.Fernandez-DelgadoR.Castano-RodriguezC.AlcarazA.TorresJ.AguilellaV.M.et al.Severe" exact="acute" post="respiratory syndrome coronavirus envelope protein ion channel activity promotes"/>
  <result pre="membrane protein that is incorporated into virionsVirology199218866667510.1016/0042-6822(92)90521-P1316677 53.Nieto-TorresJ.L.DediegoM.L.Verdia-BaguenaC.Jimenez-GuardenoJ.M.Regla-NavaJ.A.Fernandez-DelgadoR.Castano-RodriguezC.AlcarazA.TorresJ.AguilellaV.M.et al.Severe acute" exact="respiratory" post="syndrome coronavirus envelope protein ion channel activity promotes virus"/>
  <result pre="protein that is incorporated into virionsVirology199218866667510.1016/0042-6822(92)90521-P1316677 53.Nieto-TorresJ.L.DediegoM.L.Verdia-BaguenaC.Jimenez-GuardenoJ.M.Regla-NavaJ.A.Fernandez-DelgadoR.Castano-RodriguezC.AlcarazA.TorresJ.AguilellaV.M.et al.Severe acute respiratory" exact="syndrome" post="coronavirus envelope protein ion channel activity promotes virus fitness"/>
  <result pre="promotes virus fitness and pathogenesisPLoS Pathogens201410100407710.1371/journal.ppat.100407724788150 54.CollinsA.R.KnoblerR.L.PowellH.BuchmeierM.J.Monoclonal antibodies to murine" exact="hepatitis" post="virus-4 (strain JHM) define the viral glycoprotein responsible for"/>
  <result pre="54.CollinsA.R.KnoblerR.L.PowellH.BuchmeierM.J.Monoclonal antibodies to murine hepatitis virus-4 (strain JHM) define the" exact="viral" post="glycoprotein responsible for attachment and cell-cell fusionVirology198211935837110.1016/0042-6822(82)90095-26281979 55.AbrahamS.KienzleT.E.LappsW.BrianD.A.Deduced sequence"/>
  <result pre="Virol.1997715277528610.1128/JVI.71.7.5277-5286.19979188596 60.KaziL.LissenbergA.WatsonR.de GrootR.J.WeissS.R.Expression of hemagglutinin esterase protein from recombinant mouse" exact="hepatitis" post="virus enhances neurovirulenceJ. Virol.200579150641507310.1128/JVI.79.24.15064-15073.200516306577 61.KuboH.YamadaY.K.TaguchiF.Localization of neutralizing epitopes and"/>
  <result pre="62.ChengP.K.WongD.A.TongL.K.IpS.M.LoA.C.LauC.S.YeungE.Y.LimW.W.Viral shedding patterns of coronavirus in patients with probable severe" exact="acute" post="respiratory syndromeLancet20043631699170010.1016/S0140-6736(04)16255-715158632 63.NedellecP.DvekslerG.S.DanielsE.TurbideC.ChowB.BasileA.A.HolmesK.V.BeaucheminN.Bgp2, a new member of the carcinoembryonic"/>
  <result pre="shedding patterns of coronavirus in patients with probable severe acute" exact="respiratory" post="syndromeLancet20043631699170010.1016/S0140-6736(04)16255-715158632 63.NedellecP.DvekslerG.S.DanielsE.TurbideC.ChowB.BasileA.A.HolmesK.V.BeaucheminN.Bgp2, a new member of the carcinoembryonic antigen-related"/>
  <result pre="carcinoembryonic antigen-related gene family, encodes an alternative receptor for mouse" exact="hepatitis" post="virusesJ. Virol.1994684525453710.1128/JVI.68.7.4525-4537.19948207827 64.van DoremalenN.MiazgowiczK.L.Milne-PriceS.BushmakerT.RobertsonS.ScottD.KinneJ.McLellanJ.S.ZhuJ.MunsterV.J.Host species restriction of Middle East"/>
  <result pre="hepatitis virusesJ. Virol.1994684525453710.1128/JVI.68.7.4525-4537.19948207827 64.van DoremalenN.MiazgowiczK.L.Milne-PriceS.BushmakerT.RobertsonS.ScottD.KinneJ.McLellanJ.S.ZhuJ.MunsterV.J.Host species restriction of Middle East" exact="respiratory" post="syndrome coronavirus through its receptor dipeptidyl peptidase 4J. Virol.2014889220923210.1128/JVI.00676-1424899185"/>
  <result pre="virusesJ. Virol.1994684525453710.1128/JVI.68.7.4525-4537.19948207827 64.van DoremalenN.MiazgowiczK.L.Milne-PriceS.BushmakerT.RobertsonS.ScottD.KinneJ.McLellanJ.S.ZhuJ.MunsterV.J.Host species restriction of Middle East respiratory" exact="syndrome" post="coronavirus through its receptor dipeptidyl peptidase 4J. Virol.2014889220923210.1128/JVI.00676-1424899185 65.LiW.MooreM.J.VasilievaN.SuiJ.WongS.K.BerneM.A.SomasundaranM.SullivanJ.L.LuzuriagaK.GreenoughT.C.et"/>
  <result pre="coronavirus spike protein is a class I virus fusion protein:" exact="Structural" post="and functional characterization of the fusion core complexJ. Virol.2003778801881110.1128/JVI.77.16.8801-8811.200312885899"/>
  <result pre="extends 16 nucleotides into open reading frame 1J. Virol.2011855593560510.1128/JVI.00263-1121430057 72.LiuP.LiL.KeaneS.C.YangD.LeibowitzJ.L.GiedrocD.P.Mouse" exact="hepatitis" post="virus stem-loop 2 adopts a Uynmg (U)a-like tetraloop structure"/>
  <result pre="coronavirus transcriptionJ. Virol.200781202910.1128/JVI.01358-0616928755 77.Krijnse-LockerJ.EricssonM.RottierP.J.M.GriffithsG.Characterization of the budding compartment of mouse" exact="hepatitis" post="virus: Evidence that transport from the RER to the"/>
  <result pre="85.ChanJ.F.YaoY.YeungM.L.DengW.BaoL.JiaL.LiF.XiaoC.GaoH.YuP.et al.Treatment with Lopinavir/Ritonavir or Interferon-Î²1b Improves Outcome of MERS-CoV" exact="Infection" post="in a Nonhuman Primate Model of Common MarmosetJ. Infect."/>
  <result pre="MarmosetJ. Infect. Dis.20152121904191310.1093/infdis/jiv39226198719 86.ArabiY.M.AlothmanA.BalkhyH.H.Al-DawoodA.Al JohaniS.Al HarbiS.KojanS.Al JeraisyM.DeebA.M.AssiriA.M.Treatment of Middle East" exact="Respiratory" post="Syndrome with a combination of lopinavir-ritonavir and interferon-Î²1b (MIRACLE)"/>
  <result pre="Infect. Dis.20152121904191310.1093/infdis/jiv39226198719 86.ArabiY.M.AlothmanA.BalkhyH.H.Al-DawoodA.Al JohaniS.Al HarbiS.KojanS.Al JeraisyM.DeebA.M.AssiriA.M.Treatment of Middle East Respiratory" exact="Syndrome" post="with a combination of lopinavir-ritonavir and interferon-Î²1b (MIRACLE) trial:"/>
  <result pre="trialTrials2018198110.1186/s13063-017-2427-029382391 87.CaoB.WangY.WenD.LiuW.WangJ.FanG.RuangL.SongB.CaiY.WeiM.et al.A trial of Lopinavir-Ritonavir in Adults Hospitalized with" exact="Severe" post="Covid-19N. Engl. J. Med.202010.1056/NEJMoa2001282 88.PrujisssersA.J.DenisonM.R.Nucleoside analogues for the treatment"/>
  <result pre="Med. Chem. Lett.2015252923292610.1016/j.bmcl.2015.05.03926048809 91.MurphyB.G.PerronM.MurakamiE.BauerK.ParkY.EckstrandC.LiepnieksM.PedersenN.C.The nucleoside analog GS-441524 strongly inhibits feline" exact="infectious" post="peritonitis (FIP) virus in tissue culture and in experimental"/>
  <result pre="Chem. Lett.2015252923292610.1016/j.bmcl.2015.05.03926048809 91.MurphyB.G.PerronM.MurakamiE.BauerK.ParkY.EckstrandC.LiepnieksM.PedersenN.C.The nucleoside analog GS-441524 strongly inhibits feline infectious" exact="peritonitis" post="(FIP) virus in tissue culture and in experimental cat"/>
  <result pre="peritonitis (FIP) virus in tissue culture and in experimental cat" exact="infection" post="studiesVet. Microbiol.201821922623310.1016/j.vetmic.2018.04.02629778200 92.OmraniA.S.SaadM.M.BaigK.BahloulA.Abdul-MatinM.AlaidaroosA.Y.AlmakhlafiG.A.AlbarrakM.M.MemishZ.A.AlbarrakA.M.Ribavirin and interferon alpha-2a for severe Middle"/>
  <result pre="studiesVet. Microbiol.201821922623310.1016/j.vetmic.2018.04.02629778200 92.OmraniA.S.SaadM.M.BaigK.BahloulA.Abdul-MatinM.AlaidaroosA.Y.AlmakhlafiG.A.AlbarrakM.M.MemishZ.A.AlbarrakA.M.Ribavirin and interferon alpha-2a for severe Middle East" exact="respiratory" post="syndrome coronavirus infection: A retrospective cohort studyLancet Infect. Dis.2014141090109510.1016/S1473-3099(14)70920-X25278221"/>
  <result pre="Microbiol.201821922623310.1016/j.vetmic.2018.04.02629778200 92.OmraniA.S.SaadM.M.BaigK.BahloulA.Abdul-MatinM.AlaidaroosA.Y.AlmakhlafiG.A.AlbarrakM.M.MemishZ.A.AlbarrakA.M.Ribavirin and interferon alpha-2a for severe Middle East respiratory" exact="syndrome" post="coronavirus infection: A retrospective cohort studyLancet Infect. Dis.2014141090109510.1016/S1473-3099(14)70920-X25278221 93.LoM.K.JordanR.ArveyA.SudhamsuJ.Shrivastava-RanjanP.HotardA.L.FlintM.McMullanL.K.SiegelD.ClarkeM.O.et"/>
  <result pre="compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East" exact="respiratory" post="syndrome coronavirusJ. Biol. Chem.202010.1074/jbc.AC120.01305632094225 96.WangM.CaoR.ZhangL.YangX.LiuJ.XuM.ShiZ.HuZ.ZhongW.XiaoG.Remdesivir and chloroquine effectively inhibit"/>
  <result pre="remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory" exact="syndrome" post="coronavirusJ. Biol. Chem.202010.1074/jbc.AC120.01305632094225 96.WangM.CaoR.ZhangL.YangX.LiuJ.XuM.ShiZ.HuZ.ZhongW.XiaoG.Remdesivir and chloroquine effectively inhibit the"/>
  <result pre="Derivatives and Biological ActivityMolecules201621151310.3390/molecules21111513 99.TanE.L.C.Eong OoiE.LinC.-Y.Cheng TanH.LingA.E.LimB.StantonL.W.Inhibition of SARS Coronavirus" exact="Infection" post="In Vitro with Clinically Approved DrugsEmerg. Inf. Dis.20041058158610.3201/eid1004.030458 100.HaviemikJ.StefanikM.FoitikovaM.KaliS.TordoN.RudolfI.HubalekZ.EyerL.RuzekD.Arbidol"/>
  <result pre="Rep.20188898910.1038/s41598-018-27224-429895962 102.DengL.LiC.ZengQ.LiuX.LiX.ZhangH.HongZ.XiaJ.Arbidol combined with LPV/r versus LPV/r alone against Corona" exact="Virus Disease" post="2019: A retrospective cohort studyJ. Infect.202010.1016/j.jinf.2020.03.002 103.GautretP.LagierJ.-C.ParolaP.HoangV.T.MeddebL.MailheM.DoudierB.CourjonJ.GiordanengoV.VieiraE.V.et al.Hydroxychloroquine and"/>
  <result pre="102.DengL.LiC.ZengQ.LiuX.LiX.ZhangH.HongZ.XiaJ.Arbidol combined with LPV/r versus LPV/r alone against Corona Virus" exact="Disease" post="2019: A retrospective cohort studyJ. Infect.202010.1016/j.jinf.2020.03.002 103.GautretP.LagierJ.-C.ParolaP.HoangV.T.MeddebL.MailheM.DoudierB.CourjonJ.GiordanengoV.VieiraE.V.et al.Hydroxychloroquine and"/>
  <result pre="and therapeutic procedure for four cases with 2019 novel coronavirus" exact="pneumonia" post="receiving combined Chinese and Western medicine treatmentBiosci. Trends202014646810.5582/bst.2020.0103032037389 106.HoffmannM.Kleine-WeberH.SchroederS.KrÃ¼gerN.HerrlerT.ErichsenS.SchiergensT.S.HerrlerG.WuN.NitscheA.et"/>
  <result pre="SARS-CoV infectionbioRxiv2020preprint10.1101/2020.03.11.987958 110.VincentM.J.BergeronE.BenjannetS.EricksonB.R.RollinP.E.KsiazekT.G.SeidahG.S.NicholS.T.Chlkoroquine is a potent inhibitor of SARS coronavirus" exact="infection" post="and spreadVirol. J.200526910.1186/1743-422X-2-6916115318 111.ColsonP.RolainJ.-M.RaoultD.Chloroquine for the 2019 novel coronavirus"/>
  <result pre="A recommendation to examine the effect of hydrochloroquine in preventing" exact="infection" post="and progressionJ. Antimicrob. Chemother.202011410.1093/jac/dkaa114 113.Di PierroF.BertuccioliA.CavecchiaI.Possible therapeutic role of"/>
  <result pre="prescription lianhuaqingwen capsule exerts anti-influenza activity through the inhibition of" exact="viral" post="propagation and impacts immune functionBMC Complement Altern. Med.20171713010.1186/s12906-017-1585-728235408 115.MoenM.D.WagstaffA.J.Losartan:"/>
  <result pre="Complement Altern. Med.20171713010.1186/s12906-017-1585-728235408 115.MoenM.D.WagstaffA.J.Losartan: A review of its use in" exact="stroke" post="risk reduction in patients with hypertension and left ventricular"/>
  <result pre="of its use in stroke risk reduction in patients with" exact="hypertension" post="and left ventricular hypertrophyDrugs2005652657267410.2165/00003495-200565180-0001216392883 116.LeeR.C.FeinbaumR.L.AmbrosV.TheC.elegans heterochronic gene lin-4 encodes"/>
  <result pre="encodes small RNAs with antisense complimentary to lin-14Cell19937584385410.1016/0092-8674(93)90529-Y8252621 117.LundstromK.Micro-RNA in" exact="disease" post="and gene therapyCurr. Drug Discov. Technol.20118768610.2174/15701631179556385721513487 118.ShiY.Mammalian RNAi for"/>
  <result pre="SARS?Gene Ther.20061387187210.1038/sj.gt.330268217262907 122.LuC.Y.HuangH.-Y.YangT.H.ChangL.Y.LeeC.Y.HuangL.M.siRNA silencing of angiotensin-converting enzyme 2 reduced severe" exact="acute" post="respiratory syndrome-associated coronavirus replications in Vero cellsEur. J. Clin."/>
  <result pre="Ther.20061387187210.1038/sj.gt.330268217262907 122.LuC.Y.HuangH.-Y.YangT.H.ChangL.Y.LeeC.Y.HuangL.M.siRNA silencing of angiotensin-converting enzyme 2 reduced severe acute" exact="respiratory" post="syndrome-associated coronavirus replications in Vero cellsEur. J. Clin. Microbiol."/>
  <result pre="the functional roles of host cell proteins involved in coronavirus" exact="infection" post="using highly specific and scalable RNA interference (RNAi) approachMethods"/>
  <result pre="of Potential RNAi (miRNA and siRNA) Molecules for Middle East" exact="Respiratory" post="Syndrome Coronavirus (MERS-CoV) Gene Silencing by Computational MethodInterdiscip. Sci.2015725726510.1007/s12539-015-0266-926223545"/>
  <result pre="Potential RNAi (miRNA and siRNA) Molecules for Middle East Respiratory" exact="Syndrome" post="Coronavirus (MERS-CoV) Gene Silencing by Computational MethodInterdiscip. Sci.2015725726510.1007/s12539-015-0266-926223545 125.McDonaghP.SheehyP.A.NorrisJ.M.Combination"/>
  <result pre="peptide vaccine design and target site depiction against Middle East" exact="Respiratory" post="Syndrome Coronavirus: An immune-informatics studyJ. Transl. Med.20191736210.1186/s12967-019-2116-831703698 137.SrivastavaS.KamthaniaM.SinghS.SaxenaA.K.SharmaN.Structural basis"/>
  <result pre="vaccine design and target site depiction against Middle East Respiratory" exact="Syndrome" post="Coronavirus: An immune-informatics studyJ. Transl. Med.20191736210.1186/s12967-019-2116-831703698 137.SrivastavaS.KamthaniaM.SinghS.SaxenaA.K.SharmaN.Structural basis of"/>
  <result pre="137.SrivastavaS.KamthaniaM.SinghS.SaxenaA.K.SharmaN.Structural basis of development of multi-epitope vaccine against Middle East" exact="respiratory" post="syndrome using in silico approachInfect. Drug Resist.2018112377239110.2147/IDR.S17511430538505 138.WangN.RosenO.WangL.TurnerH.L.StevensL.J.CorbettK.S.BowmanC.A.PallesenJ.ShiW.ZhangY.et al.Structural"/>
  <result pre="basis of development of multi-epitope vaccine against Middle East respiratory" exact="syndrome" post="using in silico approachInfect. Drug Resist.2018112377239110.2147/IDR.S17511430538505 138.WangN.RosenO.WangL.TurnerH.L.StevensL.J.CorbettK.S.BowmanC.A.PallesenJ.ShiW.ZhangY.et al.Structural Definition"/>
  <result pre="Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV" exact="Immunological" post="StudiesViruses20201225410.3390/v12030254 141.ZakhartchoukA.N.ViswanathanN.MoshynskyyI.PetricM.BabiukL.A.Optimization of a DNA vaccine against SARSDNA Cell"/>
  <result pre="a DNA vaccine against SARSDNA Cell Biol.20072672172610.1089/dna.2007.061617665998 142.CallendretB.LorinV.CharneauP.MarianneauP.ContaminH.BettonJ.M.van der WerfS.EscriouN.Heterologous" exact="viral" post="RNA export elements improve expression of severe acute respiratory"/>
  <result pre="der WerfS.EscriouN.Heterologous viral RNA export elements improve expression of severe" exact="acute" post="respiratory syndrome (SARS) coronavirus spike protein and protective efficacy"/>
  <result pre="WerfS.EscriouN.Heterologous viral RNA export elements improve expression of severe acute" exact="respiratory" post="syndrome (SARS) coronavirus spike protein and protective efficacy of"/>
  <result pre="viral RNA export elements improve expression of severe acute respiratory" exact="syndrome" post="(SARS) coronavirus spike protein and protective efficacy of DNA"/>
  <result pre="targeting turkey coronavirus spike protein fragment containing neutralizing epitope against" exact="infectious" post="challengeVet. Immunol. Immunopathol.201315235936910.1016/j.vetimm.2013.01.00923428360 145.XueR.TianY.ZhangY.ZhangM.TianF.MaJ.JiangS.Efficacy and immunogenicity of a live"/>
  <result pre="of a live L. acidophilus expressing SAD epitope of transmissible" exact="gastroenteritis" post="virus as an oral vaccineActa Virol.20196330130810.4149/av_2019_31031507196 146.NyonM.P.DuL.TsengC.K.SeidC.A.PolletJ.NaceancenoK.S.AgrawalA.AlgaissiA.PengB.H.TaiW.et al.Engineering a"/>
  <result pre="gastroenteritis virus as an oral vaccineActa Virol.20196330130810.4149/av_2019_31031507196 146.NyonM.P.DuL.TsengC.K.SeidC.A.PolletJ.NaceancenoK.S.AgrawalA.AlgaissiA.PengB.H.TaiW.et al.Engineering a" exact="stable" post="CHO cell line for the expression of a MERS-coronavirus"/>
  <result pre="potential for development of plant-derived oral vaccinesExp. Biol. Med.20062311346135210.1177/153537020623100808 148.PogrebnyakN.GolovkinM.AndrianovV.SpitsinS.SmirnovY.EgolfR.KoprowskiH.Severe" exact="acute" post="respiratory syndrome (SARS) S protein production in plants: Development"/>
  <result pre="for development of plant-derived oral vaccinesExp. Biol. Med.20062311346135210.1177/153537020623100808 148.PogrebnyakN.GolovkinM.AndrianovV.SpitsinS.SmirnovY.EgolfR.KoprowskiH.Severe acute" exact="respiratory" post="syndrome (SARS) S protein production in plants: Development of"/>
  <result pre="development of plant-derived oral vaccinesExp. Biol. Med.20062311346135210.1177/153537020623100808 148.PogrebnyakN.GolovkinM.AndrianovV.SpitsinS.SmirnovY.EgolfR.KoprowskiH.Severe acute respiratory" exact="syndrome" post="(SARS) S protein production in plants: Development of recombinant"/>
  <result pre="150.DoV.T.JangJ.ParkJ.DaoH.T.KimK.HahnT.W.Recombinant adenovirus carrying a core neutralizing epitope of porcine epidemic" exact="diarrhea" post="virus and heat-labile enterotoxin B of Escherichia coli as"/>
  <result pre="den BrandJ.M.RajV.S.VolzA.WohlseinP.SmitsS.L.SchipperD.BestebroerT.M.OkbaN.FuxR.et al.An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV" exact="infection" post="in dromedary camelsScience2016351778110.1126/science.aad128326678878 152.VeitS.JanyS.FuxR.SutterG.VolzA.CD8+ T Cells Responding to the"/>
  <result pre="dromedary camelsScience2016351778110.1126/science.aad128326678878 152.VeitS.JanyS.FuxR.SutterG.VolzA.CD8+ T Cells Responding to the Middle East" exact="Respiratory" post="Syndrome Coronavirus Nucleocapsid Delivered by Vaccinia Virus MVA in"/>
  <result pre="camelsScience2016351778110.1126/science.aad128326678878 152.VeitS.JanyS.FuxR.SutterG.VolzA.CD8+ T Cells Responding to the Middle East Respiratory" exact="Syndrome" post="Coronavirus Nucleocapsid Delivered by Vaccinia Virus MVA in MiceViruses20181071810.3390/v10120718"/>
  <result pre="to the Middle East Respiratory Syndrome Coronavirus Nucleocapsid Delivered by" exact="Vaccinia" post="Virus MVA in MiceViruses20181071810.3390/v10120718 153.FaberM.LamirandeE.W.RobertsA.RiceA.B.KoprowskiH.DietscholdB.SchnellM.J.A single imunization with a"/>
  <result pre="MiceViruses20181071810.3390/v10120718 153.FaberM.LamirandeE.W.RobertsA.RiceA.B.KoprowskiH.DietscholdB.SchnellM.J.A single imunization with a rhabdovirus-based vector expressing severe" exact="acute" post="respiratory syndrome coronavirus (SARS-CoV) S protein results in the"/>
  <result pre="153.FaberM.LamirandeE.W.RobertsA.RiceA.B.KoprowskiH.DietscholdB.SchnellM.J.A single imunization with a rhabdovirus-based vector expressing severe acute" exact="respiratory" post="syndrome coronavirus (SARS-CoV) S protein results in the production"/>
  <result pre="single imunization with a rhabdovirus-based vector expressing severe acute respiratory" exact="syndrome" post="coronavirus (SARS-CoV) S protein results in the production of"/>
  <result pre="mice from lethal challenge from influenza virus and heterologous severe" exact="acute" post="respiratory syndrome coronavirusJ. Virol.20118521723010.1128/JVI.01805-1020980507 156.BennettR.P.DalbyB.Protein delivery using VP22Nat. Biotechnol.2002202010.1038/nbt0102-2011753353"/>
  <result pre="from lethal challenge from influenza virus and heterologous severe acute" exact="respiratory" post="syndrome coronavirusJ. Virol.20118521723010.1128/JVI.01805-1020980507 156.BennettR.P.DalbyB.Protein delivery using VP22Nat. Biotechnol.2002202010.1038/nbt0102-2011753353 157.AlmazanF.GalanC.EnjuanesL.Engineering"/>
  <result pre="lethal challenge from influenza virus and heterologous severe acute respiratory" exact="syndrome" post="coronavirusJ. Virol.20118521723010.1128/JVI.01805-1020980507 156.BennettR.P.DalbyB.Protein delivery using VP22Nat. Biotechnol.2002202010.1038/nbt0102-2011753353 157.AlmazanF.GalanC.EnjuanesL.Engineering infectious"/>
  <result pre="respiratory syndrome coronavirusJ. Virol.20118521723010.1128/JVI.01805-1020980507 156.BennettR.P.DalbyB.Protein delivery using VP22Nat. Biotechnol.2002202010.1038/nbt0102-2011753353 157.AlmazanF.GalanC.EnjuanesL.Engineering" exact="infectious" post="cDNAs of coronavirus as bacterial artificial chromosomesMethods Mol. Biol.200845427529119057870"/>
  <result pre="delivery using VP22Nat. Biotechnol.2002202010.1038/nbt0102-2011753353 157.AlmazanF.GalanC.EnjuanesL.Engineering infectious cDNAs of coronavirus as" exact="bacterial" post="artificial chromosomesMethods Mol. Biol.200845427529119057870 158.ShanmugaraiB.MallaA.PhoolcharoenW.Emergence of Novel Coronavirus 2019-nCoV:"/>
  <result pre="phosphate has shown apparent efficacy in treatment of COVID-19 associated" exact="pneumonia" post="in clinical studiesBiosci. Trends202014727310.5582/bst.2020.0104732074550 174.ChenZ.HuJ.ZhangZ.JiangS.HanS.YanD.ZhuangR.HuB.ZhangZ.Efficacy of hydroxychloroquine in patients"/>
  <result pre="trial. Version 2medRxiv202010.1101/2020.03.22.20040758 175.YanD.ZhangZ.Therapeutic Effect of Hydroxychloroquine on Novel Coronavirus" exact="Pneumonia" post="(COVID-19)Chinese Clinical Trials RegistryAvailable online: http://www.chictr.org.cn/showproj.aspx?proj=48880(accessed on 28 April"/>
  <result pre="Clinical Trials RegistryAvailable online: http://www.chictr.org.cn/showproj.aspx?proj=48880(accessed on 28 April 2020) 176.MurphyM.CarmichaelA.J.Fatal" exact="toxic epidermal necrolysis" post="associated with hydroxychloroquineClin. Exp. Dermatol.20012645745810.1046/j.1365-2230.2001.00857-3.x11488840 177.MakinA.J.WendonJ.FittS.PortmannB.C.WilliamsR.Fulminant hepatic failure secondary"/>
  <result pre="epidermal necrolysis associated with hydroxychloroquineClin. Exp. Dermatol.20012645745810.1046/j.1365-2230.2001.00857-3.x11488840 177.MakinA.J.WendonJ.FittS.PortmannB.C.WilliamsR.Fulminant hepatic failure" exact="secondary" post="to hydroxychloroquineGut19943556957010.1136/gut.35.4.5698175002 178.ChorinE.DaiM.ShulmanE.WadhwaniL.Bar-CohenR.BarbhayiaC.AizerA.HolmesD.BernsteinS.SpinelliM.et al.The QT interval in patients with"/>
  <result pre="to hydroxychloroquineGut19943556957010.1136/gut.35.4.5698175002 178.ChorinE.DaiM.ShulmanE.WadhwaniL.Bar-CohenR.BarbhayiaC.AizerA.HolmesD.BernsteinS.SpinelliM.et al.The QT interval in patients with SARS-CoV-2" exact="infection" post="treated with hydroxychloroquine/azithromycinmedRxiv202010.1101/2020.04.02.20047050v1 179.LiY.XieZ.LinW.CaiW.WenC.GuanY.MoX.WangJ.WangY.PengP.et al.An exploratory randomized, controlled study"/>
  <result pre="on the efficacy and safety of lopinavir/ritonavir or arbidol treating" exact="adult" post="patients hospitalized with mild/moderate COVID-19 (ELACOI)medRxiv202010.1101/2020.03.19.20038984 180.Available online: www.who.int/blueprint/priority-diseases/key-action/novel-coronavirus-landscape-ncov.pdf(accessed"/>
  <result pre="source of coronavirusNature2020579181910.1038/d41586-020-00548-w Figure 1 Schematic illustration of the severe" exact="acute" post="respiratory syndrome-coronavirus (SARS-CoV)-2 genome. ORF1a and ORF1b encode the"/>
  <result pre="of coronavirusNature2020579181910.1038/d41586-020-00548-w Figure 1 Schematic illustration of the severe acute" exact="respiratory" post="syndrome-coronavirus (SARS-CoV)-2 genome. ORF1a and ORF1b encode the non-structural"/>
  <result pre="SARS-CoV-2. The attachment occurs at ACE2, followed by release of" exact="viral" post="RNA into the cytoplasm. The replicase (REP) complex is"/>
  <result pre="envelope (E) and membrane (M) proteins go through the ERâ€&quot;Golgi" exact="intermediate" post="compartment (ERGIC) and Golgi before the assembly of virus"/>
  <result pre="released. biomedicines-08-00109-t001_Table 1Table 1 Coronavirus-based diseases in animals and humans." exact="Virus Disease" post="Effect Ref. TGEV Gastroenteritis in pigs High morbidity, mortality"/>
  <result pre="biomedicines-08-00109-t001_Table 1Table 1 Coronavirus-based diseases in animals and humans. Virus" exact="Disease" post="Effect Ref. TGEV Gastroenteritis in pigs High morbidity, mortality"/>
  <result pre="PEDV Gastroenteritis in pigs High morbidity, mortality [4] PHEV Enteric" exact="infection" post="Diarrhea, encephalitis [5] BCoV Respiratory tract infection Significant loss"/>
  <result pre="in pigs High morbidity, mortality [4] PHEV Enteric infection Diarrhea," exact="encephalitis" post="[5] BCoV Respiratory tract infection Significant loss in cattle"/>
  <result pre="morbidity, mortality [4] PHEV Enteric infection Diarrhea, encephalitis [5] BCoV" exact="Respiratory" post="tract infection Significant loss in cattle industry [6,7] RCoV"/>
  <result pre="[4] PHEV Enteric infection Diarrhea, encephalitis [5] BCoV Respiratory tract" exact="infection" post="Significant loss in cattle industry [6,7] RCoV Respiratory tract"/>
  <result pre="Respiratory tract infection Significant loss in cattle industry [6,7] RCoV" exact="Respiratory" post="tract infection Model system [8] IBV Respiratory infections, renal"/>
  <result pre="infection Significant loss in cattle industry [6,7] RCoV Respiratory tract" exact="infection" post="Model system [8] IBV Respiratory infections, renal disease Significant"/>
  <result pre="industry [6,7] RCoV Respiratory tract infection Model system [8] IBV" exact="Respiratory" post="infections, renal disease Significant losses in the chicken industry"/>
  <result pre="RCoV Respiratory tract infection Model system [8] IBV Respiratory infections," exact="renal disease" post="Significant losses in the chicken industry [7,9] FCoV Respiratory"/>
  <result pre="Respiratory tract infection Model system [8] IBV Respiratory infections, renal" exact="disease" post="Significant losses in the chicken industry [7,9] FCoV Respiratory"/>
  <result pre="renal disease Significant losses in the chicken industry [7,9] FCoV" exact="Respiratory" post="tract infection Mild or asymptomatic [10] FIPV Infectious peritonitis"/>
  <result pre="Significant losses in the chicken industry [7,9] FCoV Respiratory tract" exact="infection" post="Mild or asymptomatic [10] FIPV Infectious peritonitis Lethal FIP"/>
  <result pre="[7,9] FCoV Respiratory tract infection Mild or asymptomatic [10] FIPV" exact="Infectious" post="peritonitis Lethal FIP [11] SW1 Respiratory, acute liver SW1"/>
  <result pre="FCoV Respiratory tract infection Mild or asymptomatic [10] FIPV Infectious" exact="peritonitis" post="Lethal FIP [11] SW1 Respiratory, acute liver SW1 found"/>
  <result pre="Respiratory tract infection Mild or asymptomatic [10] FIPV Infectious peritonitis" exact="Lethal" post="FIP [11] SW1 Respiratory, acute liver SW1 found in"/>
  <result pre="asymptomatic [10] FIPV Infectious peritonitis Lethal FIP [11] SW1 Respiratory," exact="acute" post="liver SW1 found in deceased whale [13] Bat CoV"/>
  <result pre="acute liver SW1 found in deceased whale [13] Bat CoV" exact="Respiratory" post="tract infection Potential threat of epidemics [14] SHC014-CoV Risk"/>
  <result pre="SW1 found in deceased whale [13] Bat CoV Respiratory tract" exact="infection" post="Potential threat of epidemics [14] SHC014-CoV Risk of epidemic"/>
  <result pre="epidemic Chimeric CoV presents risk [15] MHV Respiratory, enteric, neurological" exact="infections" post="Mouse model for human disease [16] A59, JHMV Chronic"/>
  <result pre="Chimeric CoV presents risk [15] MHV Respiratory, enteric, neurological infections" exact="Mouse" post="model for human disease [16] A59, JHMV Chronic demyelination"/>
  <result pre="[15] MHV Respiratory, enteric, neurological infections Mouse model for human" exact="disease" post="[16] A59, JHMV Chronic demyelination Mouse model for MS"/>
  <result pre="neurological infections Mouse model for human disease [16] A59, JHMV" exact="Chronic" post="demyelination Mouse model for MS [17] Î± HCoV-229E Respiratory"/>
  <result pre="Mouse model for human disease [16] A59, JHMV Chronic demyelination" exact="Mouse" post="model for MS [17] Î± HCoV-229E Respiratory infection 15%â€&quot;30%"/>
  <result pre="JHMV Chronic demyelination Mouse model for MS [17] Î± HCoV-229E" exact="Respiratory" post="infection 15%â€&quot;30% of annual common cold [18] Î± HCoV-NL63"/>
  <result pre="Chronic demyelination Mouse model for MS [17] Î± HCoV-229E Respiratory" exact="infection" post="15%â€&quot;30% of annual common cold [18] Î± HCoV-NL63 Respiratory"/>
  <result pre="Respiratory infection 15%â€&quot;30% of annual common cold [18] Î± HCoV-NL63" exact="Respiratory" post="infection Also associated with croup [18,19] Î² HcoV-OC43 Respiratory"/>
  <result pre="infection 15%â€&quot;30% of annual common cold [18] Î± HCoV-NL63 Respiratory" exact="infection" post="Also associated with croup [18,19] Î² HcoV-OC43 Respiratory infection"/>
  <result pre="common cold [18] Î± HCoV-NL63 Respiratory infection Also associated with" exact="croup" post="[18,19] Î² HcoV-OC43 Respiratory infection 15%â€&quot;30% of annual common"/>
  <result pre="HCoV-NL63 Respiratory infection Also associated with croup [18,19] Î² HcoV-OC43" exact="Respiratory" post="infection 15%â€&quot;30% of annual common cold [20] Î² HcoV-HKU1"/>
  <result pre="Respiratory infection Also associated with croup [18,19] Î² HcoV-OC43 Respiratory" exact="infection" post="15%â€&quot;30% of annual common cold [20] Î² HcoV-HKU1 Respiratory"/>
  <result pre="Respiratory infection 15%â€&quot;30% of annual common cold [20] Î² HcoV-HKU1" exact="Respiratory" post="infection 15%â€&quot;30% of annual common cold [20] SARS-CoV SARS"/>
  <result pre="infection 15%â€&quot;30% of annual common cold [20] Î² HcoV-HKU1 Respiratory" exact="infection" post="15%â€&quot;30% of annual common cold [20] SARS-CoV SARS Epidemic"/>
  <result pre="Respiratory infection 15%â€&quot;30% of annual common cold [20] SARS-CoV SARS" exact="Epidemic" post="with 774 deaths [21,22] MERS-CoV MERS Epidemic with 333"/>
  <result pre="[20] SARS-CoV SARS Epidemic with 774 deaths [21,22] MERS-CoV MERS" exact="Epidemic" post="with 333 deaths [23] Î±, Î±-coronavirus; A59, type of"/>
  <result pre="BCoV, bovine CoV; CoV, coronavirus; FCoV, Feline coronavirus; FIP, feline" exact="infectious" post="peritonitis; FIPV, feline infectious peritonitis virus; IBV, infectious bronchitis"/>
  <result pre="coronavirus; FCoV, Feline coronavirus; FIP, feline infectious peritonitis; FIPV, feline" exact="infectious" post="peritonitis virus; IBV, infectious bronchitis virus; JHMV, type of"/>
  <result pre="FCoV, Feline coronavirus; FIP, feline infectious peritonitis; FIPV, feline infectious" exact="peritonitis" post="virus; IBV, infectious bronchitis virus; JHMV, type of MHV;"/>
  <result pre="FIP, feline infectious peritonitis; FIPV, feline infectious peritonitis virus; IBV," exact="infectious" post="bronchitis virus; JHMV, type of MHV; MERS-CoV, Middle East"/>
  <result pre="feline infectious peritonitis; FIPV, feline infectious peritonitis virus; IBV, infectious" exact="bronchitis" post="virus; JHMV, type of MHV; MERS-CoV, Middle East respiratory"/>
  <result pre="infectious bronchitis virus; JHMV, type of MHV; MERS-CoV, Middle East" exact="respiratory" post="syndrome-coronavirus; MHV, mouse hepatitis virus; MS, multiple sclerosis; PEDV,"/>
  <result pre="type of MHV; MERS-CoV, Middle East respiratory syndrome-coronavirus; MHV, mouse" exact="hepatitis" post="virus; MS, multiple sclerosis; PEDV, porcine epidemic diarrhea virus;"/>
  <result pre="MERS-CoV, Middle East respiratory syndrome-coronavirus; MHV, mouse hepatitis virus; MS," exact="multiple sclerosis;" post="PEDV, porcine epidemic diarrhea virus; PHEV, porcine hemagglutinating encephalomyelitis"/>
  <result pre="MHV, mouse hepatitis virus; MS, multiple sclerosis; PEDV, porcine epidemic" exact="diarrhea" post="virus; PHEV, porcine hemagglutinating encephalomyelitis virus; RCoV, rat CoV;"/>
  <result pre="multiple sclerosis; PEDV, porcine epidemic diarrhea virus; PHEV, porcine hemagglutinating" exact="encephalomyelitis" post="virus; RCoV, rat CoV; SARS-CoV, severe acute respiratory syndrome-coronavirus;"/>
  <result pre="PHEV, porcine hemagglutinating encephalomyelitis virus; RCoV, rat CoV; SARS-CoV, severe" exact="acute" post="respiratory syndrome-coronavirus; TGEV, transmissible gastroenteritis virus (TGEV); SW1, whale"/>
  <result pre="porcine hemagglutinating encephalomyelitis virus; RCoV, rat CoV; SARS-CoV, severe acute" exact="respiratory" post="syndrome-coronavirus; TGEV, transmissible gastroenteritis virus (TGEV); SW1, whale coronavirus."/>
  <result pre="RCoV, rat CoV; SARS-CoV, severe acute respiratory syndrome-coronavirus; TGEV, transmissible" exact="gastroenteritis" post="virus (TGEV); SW1, whale coronavirus. biomedicines-08-00109-t003_Table 3Table 3 Gene"/>
  <result pre="whale coronavirus. biomedicines-08-00109-t003_Table 3Table 3 Gene silencing against coronaviruses. Therapy" exact="Disease" post="Effect Ref. siRNAs SARS-CoV Inhibition of replication in Vero"/>
  <result pre="[120] SARS-CoV Suppression of SARS symptoms in primates [121] SARS-CoV" exact="Reduced" post="infection in ACE2-silenced cells [122] siRNAs, miRNAs SARS-CoV Knockdown"/>
  <result pre="SARS-CoV Suppression of SARS symptoms in primates [121] SARS-CoV Reduced" exact="infection" post="in ACE2-silenced cells [122] siRNAs, miRNAs SARS-CoV Knockdown of"/>
  <result pre="[124] siRNAs FIPV siRNA combination delays resistance [125] shRNAs PDCoV" exact="Reduced" post="titers and viral RNA in ST cells [126] PEDV"/>
  <result pre="siRNA combination delays resistance [125] shRNAs PDCoV Reduced titers and" exact="viral" post="RNA in ST cells [126] PEDV Inhibition of viral"/>
  <result pre="and viral RNA in ST cells [126] PEDV Inhibition of" exact="viral" post="RNA and replication [127] SADS-CoV Inhibition of viral RNA"/>
  <result pre="Inhibition of viral RNA and replication [127] SADS-CoV Inhibition of" exact="viral" post="RNA and replication [127] PDCoV Inhibition of viral RNA"/>
  <result pre="Inhibition of viral RNA and replication [127] PDCoV Inhibition of" exact="viral" post="RNA and replication [127] FIPV, feline infectious peritonitis virus;"/>
  <result pre="PDCoV Inhibition of viral RNA and replication [127] FIPV, feline" exact="infectious" post="peritonitis virus; MERS-CoV, Middle East respiratory syndrome-coronavirus; miRNAs, micro"/>
  <result pre="Inhibition of viral RNA and replication [127] FIPV, feline infectious" exact="peritonitis" post="virus; MERS-CoV, Middle East respiratory syndrome-coronavirus; miRNAs, micro RNAs;"/>
  <result pre="replication [127] FIPV, feline infectious peritonitis virus; MERS-CoV, Middle East" exact="respiratory" post="syndrome-coronavirus; miRNAs, micro RNAs; PDCoV, porcine deltacoronavirus; PEDV, porcine"/>
  <result pre="syndrome-coronavirus; miRNAs, micro RNAs; PDCoV, porcine deltacoronavirus; PEDV, porcine epidemic" exact="diarrhea" post="virus; SADS-CoV, swine acute diarrhea syndrome-coronavirus; SARS-CoV, severe acute"/>
  <result pre="PDCoV, porcine deltacoronavirus; PEDV, porcine epidemic diarrhea virus; SADS-CoV, swine" exact="acute" post="diarrhea syndrome-coronavirus; SARS-CoV, severe acute respiratory syndrome-coronavirus; shRNAs, short"/>
  <result pre="porcine deltacoronavirus; PEDV, porcine epidemic diarrhea virus; SADS-CoV, swine acute" exact="diarrhea" post="syndrome-coronavirus; SARS-CoV, severe acute respiratory syndrome-coronavirus; shRNAs, short hairpin"/>
  <result pre="epidemic diarrhea virus; SADS-CoV, swine acute diarrhea syndrome-coronavirus; SARS-CoV, severe" exact="acute" post="respiratory syndrome-coronavirus; shRNAs, short hairpin RNAs; siRNAs, short interfering"/>
  <result pre="diarrhea virus; SADS-CoV, swine acute diarrhea syndrome-coronavirus; SARS-CoV, severe acute" exact="respiratory" post="syndrome-coronavirus; shRNAs, short hairpin RNAs; siRNAs, short interfering RNAs;"/>
  <result pre="swine acute diarrhea syndrome-coronavirus; SARS-CoV, severe acute respiratory syndrome-coronavirus; shRNAs," exact="short" post="hairpin RNAs; siRNAs, short interfering RNAs; ST, swine testicular."/>
  <result pre="SARS-CoV, severe acute respiratory syndrome-coronavirus; shRNAs, short hairpin RNAs; siRNAs," exact="short" post="interfering RNAs; ST, swine testicular."/>
 </snippets>
</snippetsTree>
